Global Dermal Drug Delivery System Market Growth 2025-2031

Publication ID:

LPI06261477

Publication Date:

June 13, 2025

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Dermal Drug Delivery System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
DDS (drug delivery systems) are also called drug delivery systems.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淒ermal Drug Delivery System Industry Forecast鈥� looks at past sales and reviews total world Dermal Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Dermal Drug Delivery System sales for 2025 through 2031. With Dermal Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dermal Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Dermal Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dermal Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Dermal Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dermal Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dermal Drug Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermal Drug Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral
Injection
Transdermal
Segmentation by Application:
Hospital
Clinic
Home Care
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
3M
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
ALZA Corporation
BD
MedImmune
Mystic Pharmaceuticals
Generex Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dermal Drug Delivery System market?
What factors are driving Dermal Drug Delivery System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dermal Drug Delivery System market opportunities vary by end market size?
How does Dermal Drug Delivery System break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermal Drug Delivery System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Dermal Drug Delivery System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Dermal Drug Delivery System by Country/Region, 2020, 2024 & 2031
2.2 Dermal Drug Delivery System Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Transdermal
2.3 Dermal Drug Delivery System Sales by Type
2.3.1 Global Dermal Drug Delivery System Sales Market Share by Type (2020-2025)
2.3.2 Global Dermal Drug Delivery System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Dermal Drug Delivery System Sale Price by Type (2020-2025)
2.4 Dermal Drug Delivery System Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Home Care
2.5 Dermal Drug Delivery System Sales by Application
2.5.1 Global Dermal Drug Delivery System Sale Market Share by Application (2020-2025)
2.5.2 Global Dermal Drug Delivery System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Dermal Drug Delivery System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Dermal Drug Delivery System Breakdown Data by Company
3.1.1 Global Dermal Drug Delivery System Annual Sales by Company (2020-2025)
3.1.2 Global Dermal Drug Delivery System Sales Market Share by Company (2020-2025)
3.2 Global Dermal Drug Delivery System Annual Revenue by Company (2020-2025)
3.2.1 Global Dermal Drug Delivery System Revenue by Company (2020-2025)
3.2.2 Global Dermal Drug Delivery System Revenue Market Share by Company (2020-2025)
3.3 Global Dermal Drug Delivery System Sale Price by Company
3.4 Key Manufacturers Dermal Drug Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dermal Drug Delivery System Product Location Distribution
3.4.2 Players Dermal Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Dermal Drug Delivery System by Geographic Region
4.1 World Historic Dermal Drug Delivery System Market Size by Geographic Region (2020-2025)
4.1.1 Global Dermal Drug Delivery System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Dermal Drug Delivery System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Dermal Drug Delivery System Market Size by Country/Region (2020-2025)
4.2.1 Global Dermal Drug Delivery System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Dermal Drug Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dermal Drug Delivery System Sales Growth
4.4 APAC Dermal Drug Delivery System Sales Growth
4.5 Europe Dermal Drug Delivery System Sales Growth
4.6 Middle East & Africa Dermal Drug Delivery System Sales Growth
5 Americas
5.1 Americas Dermal Drug Delivery System Sales by Country
5.1.1 Americas Dermal Drug Delivery System Sales by Country (2020-2025)
5.1.2 Americas Dermal Drug Delivery System Revenue by Country (2020-2025)
5.2 Americas Dermal Drug Delivery System Sales by Type (2020-2025)
5.3 Americas Dermal Drug Delivery System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dermal Drug Delivery System Sales by Region
6.1.1 APAC Dermal Drug Delivery System Sales by Region (2020-2025)
6.1.2 APAC Dermal Drug Delivery System Revenue by Region (2020-2025)
6.2 APAC Dermal Drug Delivery System Sales by Type (2020-2025)
6.3 APAC Dermal Drug Delivery System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dermal Drug Delivery System by Country
7.1.1 Europe Dermal Drug Delivery System Sales by Country (2020-2025)
7.1.2 Europe Dermal Drug Delivery System Revenue by Country (2020-2025)
7.2 Europe Dermal Drug Delivery System Sales by Type (2020-2025)
7.3 Europe Dermal Drug Delivery System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dermal Drug Delivery System by Country
8.1.1 Middle East & Africa Dermal Drug Delivery System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Dermal Drug Delivery System Revenue by Country (2020-2025)
8.2 Middle East & Africa Dermal Drug Delivery System Sales by Type (2020-2025)
8.3 Middle East & Africa Dermal Drug Delivery System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dermal Drug Delivery System
10.3 Manufacturing Process Analysis of Dermal Drug Delivery System
10.4 Industry Chain Structure of Dermal Drug Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dermal Drug Delivery System Distributors
11.3 Dermal Drug Delivery System Customer
12 World Forecast Review for Dermal Drug Delivery System by Geographic Region
12.1 Global Dermal Drug Delivery System Market Size Forecast by Region
12.1.1 Global Dermal Drug Delivery System Forecast by Region (2026-2031)
12.1.2 Global Dermal Drug Delivery System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Dermal Drug Delivery System Forecast by Type (2026-2031)
12.7 Global Dermal Drug Delivery System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 3M
13.1.1 3M Company Information
13.1.2 3M Dermal Drug Delivery System Product Portfolios and Specifications
13.1.3 3M Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 3M Main Business Overview
13.1.5 3M Latest Developments
13.2 Antares Pharma
13.2.1 Antares Pharma Company Information
13.2.2 Antares Pharma Dermal Drug Delivery System Product Portfolios and Specifications
13.2.3 Antares Pharma Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Antares Pharma Main Business Overview
13.2.5 Antares Pharma Latest Developments
13.3 Pharmajet
13.3.1 Pharmajet Company Information
13.3.2 Pharmajet Dermal Drug Delivery System Product Portfolios and Specifications
13.3.3 Pharmajet Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pharmajet Main Business Overview
13.3.5 Pharmajet Latest Developments
13.4 Optinose
13.4.1 Optinose Company Information
13.4.2 Optinose Dermal Drug Delivery System Product Portfolios and Specifications
13.4.3 Optinose Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Optinose Main Business Overview
13.4.5 Optinose Latest Developments
13.5 Valeritas
13.5.1 Valeritas Company Information
13.5.2 Valeritas Dermal Drug Delivery System Product Portfolios and Specifications
13.5.3 Valeritas Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Valeritas Main Business Overview
13.5.5 Valeritas Latest Developments
13.6 Crossject
13.6.1 Crossject Company Information
13.6.2 Crossject Dermal Drug Delivery System Product Portfolios and Specifications
13.6.3 Crossject Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Crossject Main Business Overview
13.6.5 Crossject Latest Developments
13.7 Injex Pharma
13.7.1 Injex Pharma Company Information
13.7.2 Injex Pharma Dermal Drug Delivery System Product Portfolios and Specifications
13.7.3 Injex Pharma Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Injex Pharma Main Business Overview
13.7.5 Injex Pharma Latest Developments
13.8 ALZA Corporation
13.8.1 ALZA Corporation Company Information
13.8.2 ALZA Corporation Dermal Drug Delivery System Product Portfolios and Specifications
13.8.3 ALZA Corporation Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 ALZA Corporation Main Business Overview
13.8.5 ALZA Corporation Latest Developments
13.9 BD
13.9.1 BD Company Information
13.9.2 BD Dermal Drug Delivery System Product Portfolios and Specifications
13.9.3 BD Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BD Main Business Overview
13.9.5 BD Latest Developments
13.10 MedImmune
13.10.1 MedImmune Company Information
13.10.2 MedImmune Dermal Drug Delivery System Product Portfolios and Specifications
13.10.3 MedImmune Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 MedImmune Main Business Overview
13.10.5 MedImmune Latest Developments
13.11 Mystic Pharmaceuticals
13.11.1 Mystic Pharmaceuticals Company Information
13.11.2 Mystic Pharmaceuticals Dermal Drug Delivery System Product Portfolios and Specifications
13.11.3 Mystic Pharmaceuticals Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Mystic Pharmaceuticals Main Business Overview
13.11.5 Mystic Pharmaceuticals Latest Developments
13.12 Generex Biotechnology
13.12.1 Generex Biotechnology Company Information
13.12.2 Generex Biotechnology Dermal Drug Delivery System Product Portfolios and Specifications
13.12.3 Generex Biotechnology Dermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Generex Biotechnology Main Business Overview
13.12.5 Generex Biotechnology Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂